PDE5A and heart failure: A number of preclinical studies from our laboratory have shown that PDE-5 inhibitors have a powerful protective effect against myocardial ischemia/reperfusion (I/R) injury [14]–[18], doxorubicin and post-MI heart failure [19]–[23].